Floatz logo

CIS-DIAMMINEDICHLOROPLATINUM II

Cytoreductive Surgery

National Cancer Center, KoreaSmall moleculePhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the Cytoreductive Surgery cohort.

Asset / SponsorPhaseRating
Sodium Thiosulfate
National Cancer Center, Korea
Phase 3B
Eloxatin
Sun Yat-sen University
Phase 2CCC
Capecitabine
Sun Yat-sen University
Phase 2CCC
Irinotecan
Sun Yat-sen University
Phase 2CCC
Calcium folinate pentahydrate
Sun Yat-sen University
Phase 2CCC
FLUOROURACILUM
Sun Yat-sen University
Phase 2CCC
Pregabalin
Zhejiang Cancer Hospital
N/AD
Amitriptyline
Zhejiang Cancer Hospital
N/AD

Same molecule, other indications

CIS-DIAMMINEDICHLOROPLATINUM II is also rated in:

squamous cell lung carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →
primary peritoneal carcinomaDormant
BBB
Indicative ·
77 / 100
View asset →
adenocarcinomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →